Interaction between glymphatic and vascular systems for waste clearance in brain

Information

  • Research Project
  • 10163280
  • ApplicationId
    10163280
  • Core Project Number
    R01NS108463
  • Full Project Number
    5R01NS108463-04
  • Serial Number
    108463
  • FOA Number
    RFA-NS-18-003
  • Sub Project Id
  • Project Start Date
    9/1/2018 - 6 years ago
  • Project End Date
    5/31/2023 - a year ago
  • Program Officer Name
    BOSETTI, FRANCESCA
  • Budget Start Date
    6/1/2021 - 3 years ago
  • Budget End Date
    5/31/2022 - 2 years ago
  • Fiscal Year
    2021
  • Support Year
    04
  • Suffix
  • Award Notice Date
    5/24/2021 - 3 years ago
Organizations

Interaction between glymphatic and vascular systems for waste clearance in brain

ABSTRACT The objective of this application is to first develop and validate microvessel measurement for the entire brain to enhance detection sensitivity of microvessels by ten-fold using superparamagnetic iron oxide (SPIO) enhanced susceptibility weighted imaging (SWI, SPIO-SWI) and then to investigate the interaction between glymphatic and vascular systems for waste clearance in the diabetic brain. Emerging data indicate that the glymphatic system in the brain mediates the cerebrospinal fluid (CSF)-interstitial (ISF) exchange and solute clearance from the brain parenchyma and plays an important role in neurological diseases1-6. Despite many milestone achievements, conclusive findings on the solute efflux pathways are relatively limited. Consequently, the interaction between vascular and glymphatic systems on waste clearance, especially with neurological diseases, is unclear. The paucity of research into the efflux pathway may be attributed in part to technical difficulties, such as the challenging need to perform minimally invasive in-vivo, ultra-high detection sensitivity for tube-shaped influx and efflux pathways, and whole brain imaging. Although MRI can overcome the weak points of two-photon confocal microscopy to provide non-invasive whole brain in-vivo imaging of the glymphatic system, conventional MRI sensitivity is insufficient for the required spatial resolution for investigating microvessels of glymphatic and vascular systems. We have developed highly sensitive MRI methods (Fig. 1) which significantly improve the detection sensitivity of small vessels by using the combination of high susceptibility of MRI agents with blooming effects7-9. The new methods provide excellent tools for investigating the efflux pathways of waste clearance under normal and pathophysiological conditions. Three efflux routes have been recently proposed and solutes in the brain could reach the lymphatic network by the olfactory bulb across the ethmoid plate10, 11 or by functioning conventional lymphatic vasculature in the meninges12. We found that tracer concentration in the venous system significantly increased with diabetes (Fig. 9), thus adding a new route for brain waste clearance. Based on our novel preliminary data and published studies by others, we hypothesize that, the newly developed SPIO-SWI technique significantly increases detecting sensitivity of microvessels in both vascular and glymphatic systems, and the efflux pathways of waste clearance with and without diabetes can be identified and investigated using this optimized SPIO-SWI method. To test these hypotheses, we will first (Aim 1) further develop, optimize and validate SPIO-SWI techniques to enhance the detection sensitivity for both vascular and glymphatic microvessels. We will perform computer simulation, optimize SWI technique and experimental conditions in animal studies and then validate USPIO-SWI technique by LSCM measurements. We will then (Aim 2) investigate the interaction between vascular and glymphatic systems for waste clearance in diabetic brain using the optimized USPIO-SWI technique. Data generated from this application will provide new insights into the efflux pathways between glymphatic and vascular systems in diabetic brain.

IC Name
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
  • Activity
    R01
  • Administering IC
    NS
  • Application Type
    5
  • Direct Cost Amount
    422939
  • Indirect Cost Amount
    146252
  • Total Cost
    569191
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    853
  • Ed Inst. Type
  • Funding ICs
    NICHD:117000\NIDA:450000\NINDS:2191\
  • Funding Mechanism
    Non-SBIR/STTR RPGs
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    HENRY FORD HEALTH SYSTEM
  • Organization Department
  • Organization DUNS
    073134603
  • Organization City
    DETROIT
  • Organization State
    MI
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    482023450
  • Organization District
    UNITED STATES